FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/069888 [Registered on: 04/07/2024] Trial Registered Prospectively
Last Modified On: 10/03/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Clinical study of application shalmali kantak extract in the form of arka and gel form in pimples. 
Scientific Title of Study   A Pharmaceutico - Analytical and clinical study of Shalmalikantaka Arka along with its modified form as gel in Mukhadushika 
Trial Acronym  nill 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Indira V 
Designation  PhD scholar Assistant professor 
Affiliation  JS Ayurvedamahavidylay 
Address  OPD No 135 Dept of Shalakya tantra JS Ayurvedamahavidyalay and PD Patel Ayurveda hospital College road Nadiad

Kheda
GUJARAT
387001
India 
Phone  8050158292  
Fax    
Email  indiravenu50@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ganga Hadimani  
Designation  Professor 
Affiliation  JS Ayurvedamahavidylay 
Address  OPD No 135 Dept of Shalakya tantra JS Ayurvedamahavidyalay and PD Patel Ayurveda hospital College road Nadiad

Kheda
GUJARAT
387001
India 
Phone  8780067570  
Fax    
Email  gangupatil2001@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Ganga Hadimani  
Designation  Professor 
Affiliation  JS Ayurvedamahavidylay 
Address  OPD No 135 Dept of Shalakya tantra JS Ayurvedamahavidyalay and PD Patel Ayurveda hospital College road Nadiad

Kheda
GUJARAT
387001
India 
Phone  8780067570  
Fax    
Email  gangupatil2001@rediffmail.com  
 
Source of Monetary or Material Support  
Dept of Rasashastra evam Baishajya kalpana JS Ayurveda mahavidylay & PD Patel Ayurveda hospital College road Nadiad Kheda District Gujarat India Pin code 387001  
 
Primary Sponsor  
Name  Dr Indira V 
Address  JS Ayurvedamahavidylay & PD Patel Ayurveda hospital College road Nadiad Kheda District Gujarat India pin code 387001 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
nill   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Indira V  JS Ayurveda mahavidyala & PD Patel Ayurveda hospital college road Nadiad Gujarat  JS Ayurveda mahavidyala & PD Patel Ayurveda hospital college road Nadiad Gujarat
Kheda
GUJARAT 
8050158292

indiravenu50@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Maganbhai Adenwala Mahagujarat University Institutional ethics committee for human research  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L700||Acne vulgaris. Ayurveda Condition: YUVANAPIDAKA (MUKHADUSHIKA), ,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: shalmalikantaka Arka, Reference: Arkaprakasha 7/5, Route: Topical, Dosage Form: Arka, Dose: 10(drops), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: NA
2Comparator ArmDrugOther than Classical(1) Medicine Name: shalmalikantaka gel, Reference: NA, Route: Topical, Dosage Form: Malahara/ Ointment/ Balm, Dose: 2(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: NA
 
Inclusion Criteria  
Age From  13.00 Year(s)
Age To  35.00 Year(s)
Gender  Both 
Details  1.Patients having symptoms of Mukhadushika as mentioned in Classics are included.
2. Patients between the age group of 13 years to 35 years, irrespective of religion, sex, socio-economic status, occupation are included for the study.
 
 
ExclusionCriteria 
Details  1. Patients having Pidaka as of other Kshudra Roga and Kushta are excluded.
2. Patients associated with any Systemic and metabolic disorders are excluded.
3. Patients of the age group less than 13 years and more than 35 years are excluded.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1.it helps to cure acne.
2. helps to clear acne marks. 
once in a week, 4 times after study period. 
 
Secondary Outcome  
Outcome  TimePoints 
GAGS Score  once in a week, 4 times after study period. 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "60"
Final Enrollment numbers achieved (India)="60" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   10/07/2024 
Date of Study Completion (India) 20/09/2025 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  

Study type                 : Interventional

Interventional model: two groups assignment

Purpose                      : Treatment

     Allocation                  : Randomized

     Timing                        : prospective

     Sample                       : minimum 40

     Outcome                    : efficacy of treatment protocol

     Duration                     : 30 days

·     GROUPING:

Minimum 40 patients.

     All the patients will be divided into two groups by randomized clinical study.

 Group A:

    Minimum 20 patients.

    Drug (A): shalmalikantaka arka

     Dose                          : as required for the affected area

Duration                     : 30 days

Form                          : Arka

 Group B:

    Minimum 20 patients.

Drug (B): shalmalikantaka arka Gel

Dose                          : as required for the affected area

Duration                     : 30 days

Form                          : gel

  • 20 pts will be randomly selected and after fulfilling the inclusion criteria as mentioned in the clinical proforma will be subjected for the application of shalamalikantaka arka for a period of 30 days.
  • Mode of application of shalamalikantaka arka: Take 6-8 drops of arka and applied on effected area of face and give a gentle massage, allow it dry for 30 minutes, then face should be washed with Luke warm water.
  • Similarly,20 pts will be randomly selected who will fulfill inclusion criteria of Mukhadushika and advised to apply shalmalikantaka arka gel, twice a day for 30days.
  • Mode of application of gel: take sufficient quantity of gel and apply over the affected area of face and give a gentle massage, allow it to absorb for 30 minutes, then face should be washed with normal water.
  • Study will be carried out on the patients fulfilling the inclusion criteria of Mukhadhooshika. The result of treatment of both groups will be statistically analyzed.


 
Close